On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))
dc.contributor.author | Farci, Patrizia | |
dc.contributor.author | Marcellin, Patrick | |
dc.contributor.author | Lu, Zhi-Meng | |
dc.contributor.author | Diago, Moises | |
dc.contributor.author | Lai, Ming-Yang | |
dc.contributor.author | Kittis, G | |
dc.contributor.author | Yurdaydin, Cihan | |
dc.contributor.author | Zahm, FE | |
dc.contributor.author | Bonino, FD | |
dc.contributor.buuauthor | Gürel, Selim | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. | tr_TR |
dc.date.accessioned | 2021-08-19T09:12:48Z | |
dc.date.available | 2021-08-19T09:12:48Z | |
dc.date.issued | 2005-04 | |
dc.description | Bu çalışma, 13-17 Nisan 2005 tarihleri arasında Paris'te düzenlenen Avrupa Karaciğer Çalışmaları 40. Toplantısında bildiri olarak sunulmuştur. | tr_TR |
dc.identifier.citation | Farci, P. vd. (2005). "On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))". Journal of Hepatology, 42, 175-175. | en_US |
dc.identifier.endpage | 175 | tr_TR |
dc.identifier.issn | 0168-8278 | |
dc.identifier.startpage | 175 | tr_TR |
dc.identifier.uri | http://hdl.handle.net/11452/21473 | |
dc.identifier.volume | 42 | tr_TR |
dc.identifier.wos | 000229024000485 | tr_TR |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | CPCIS | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science | en_US |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | Journal of Hepatology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Gastroenterology & hepatology | en_US |
dc.subject.wos | Gastroenterology & hepatology | en_US |
dc.title | On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R)) | en_US |
dc.type | Meeting Abstract | |
dc.wos.quartile | Q1 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: